SUMMIT THERAPEUTICS INC COM SMMT
STOCK · ADR · CUSIP 86627R102
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersMiami, FL
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q3 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 3 |
| Q4 2022 | 4 |
| Q1 2023 | 6 |
| Q2 2023 | 4 |
| Q3 2023 | 2 |
| Q4 2023 | 2 |
| Q1 2024 | 2 |
| Q2 2024 | 2 |
| Q3 2024 | 2 |
| Q4 2024 | 7 |
| Q1 2025 | 10 |
| Q2 2025 | 12 |
| Q3 2025 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 0 | 1 |
| Q1 2024 | 1 | 1 |
| Q2 2024 | 2 | 1 |
| Q3 2024 | 1 | 1 |
| Q4 2024 | 5 | 1 |
| Q1 2025 | 10 | 2 |
| Q2 2025 | 8 | 6 |
| Q3 2025 | 0 | 12 |
Biggest buyers
| None |
Biggest sellers
| Parallel Advisors, LLC | Sold out | -2.0k |
| Farther Finance Advisors, LLC | Sold out | -560 |
| Rosenberg Matthew Hamilton | Sold out | -501 |
| EverSource Wealth Advisors, LLC | Sold out | -370 |
| Roxbury Financial LLC | Sold out | -187 |
| Park Place Capital Corp | Sold out | -62 |
| SIERRA OCEAN, LLC | Sold out | -38 |
| Rise Advisors, LLC | Sold out | -28 |
| AdvisorNet Financial, Inc | Sold out | -22 |
| Fortitude Family Office, LLC | Sold out | -15 |
Insider purchases and sales in Q3 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2023 | 3 | $5.1m | 0 | — | — |
| Q1 2024 | 2 | $786.1k | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 2 | $6.0m | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-09-11 | DUGGAN ROBERT W Co-Chief Executive Officer, director | Bought | $90.3k5.0k shares |
| 2025-09-11 | Zanganeh Mahkam Co-Chief Executive Officer, director · By Spouse | Bought | $90.3k5.0k shares |
| 2025-09-10 | DUGGAN ROBERT W Co-Chief Executive Officer, director | Bought | $5.9m333.4k shares |
| 2025-09-10 | Zanganeh Mahkam Co-Chief Executive Officer, director · By Spouse | Bought | $5.9m333.4k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2025
| Manager | Shares | Change |
|---|